探索胎儿先天性心脏病的潜在中期孕妇血清生物标志物:一项回顾性病例对照研究
概括
在怀孕中期,母体血清α-fetoprotein (AFP) 和自由人类胆性淋巴激素β子单元 (自由β-hCG) 水平的升高与胎儿先天性心脏病 (CHD) 有关. 这些标记物可能有助于非侵入性心血管疾病查.
科学领域:
- 产科和妇科 产科和妇科
- 胎儿医学 胎儿医学
- 生物标志物研究 生物标志物研究
背景情况:
- 先天性心脏病 (CHD) 是胎儿发育的一个重大问题.
- 妊娠中期的母体血清查通常评估染色体异常的风险.
- 确定胎儿心血管疾病的可靠生物标志物对于早期检测和管理至关重要.
研究的目的:
- 调查第二个三个月期间母体血清水平的α-fetoprotein (AFP) 和自由人类胆性淋巴激素β子单元 (自由β-hCG) 之间的关联,以及胎儿心血管疾病的发病率.
- 评估这些生物标志物的诊断性能,单独和与母亲年龄和妊娠日结合,用于预测胎儿心脏病.
主要方法:
- 一项追溯病例控制研究,涉及303名孕妇 (101名胎儿心脏病患者,202名对照).
- 测量母亲血清AFP和自由β-hCG水平 (作为中位数的倍数,MoM) 使用时间解析光免疫测试.
- 使用二进制逻辑回归和ROC曲线分析来评估关联和诊断准确性.
主要成果:
- 与对照组相比,在心血管疾病组中观察到明显更高的母体血清AFP MoM,自由β-hCG MoM和母体年龄.
- 升高的AFP和自由β-hCG独立地与胎儿心脏病相关 (OR分别为4.057和1.978).
- 包括AFP MoM,自由β-hCG MoM,孕妇年龄和妊娠日的组合模型实现了检测胎儿心脏病的AUC为0.794.
结论:
- 妊娠中期母亲血清AFP和自由β-hCG水平的升高与中国队列中胎儿心血管疾病风险的增加有显著关联.
- 这些生物标志物显示出作为胎儿心脏病的非侵入性查工具的潜力.
- 需要进一步的研究来验证这些发现,并完善查方案.
相关概念视频
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
214
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
214
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
334
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
334
Teratogenicity
2.8K
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
2.8K
Fetal Circulation
1.4K
Fetal circulation is a unique system that facilitates the exchange of gases, nutrients, and waste products between the developing fetus and the mother. This intricate process takes place through a special organ called the placenta.
Two umbilical arteries transport blood from the fetus to the placenta. At the placenta, the blood absorbs oxygen and nutrients while simultaneously eliminating waste products. This oxygen-enriched and nutrient-rich blood then returns to the fetus through one...
Two umbilical arteries transport blood from the fetus to the placenta. At the placenta, the blood absorbs oxygen and nutrients while simultaneously eliminating waste products. This oxygen-enriched and nutrient-rich blood then returns to the fetus through one...
1.4K
Mitral Stenosis II: Clinical features and Diagnostic Tests
37
Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
37
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
58
The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
58


